Suchergebnisse - "Hiratani, Seigo"

1

Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for “Borderline Resectable” in the Field of Surgery for Hilar Cholangiocarcinoma

von: Matsuyama, Ryusei

2018, in: World Journal of Surgery

Wird geladen...
2

Single-institution experience with gemcitabine–cisplatin combination therapy as a second-line treatment for patients with unresectable biliary tract cancer after failure of gemcitabine–S-1 combination therapy: a prospective feasibility study

von: Matsuyama, Ryusei

2018, in: Cancer chemotherapy and pharmacology

Wird geladen...
3

ASO Visual Abstract: Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma

von: Matsuyama, Ryusei

2022, in: Annals of surgical oncology

Wird geladen...
4

Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma

von: Matsuyama, Ryusei

2022, in: Annals of surgical oncology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!